Clinical Trials

Showing trials with last updates posted in 2026.

NCT05772546 | COMPLETED | PHASE2
49 participants

Avatrombopag vs. Placebo for CIT in GI Malignancies

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-31
Start Date:
2023-11-01
Completion:
2026-01-02
Conditions
  • Gastrointestinal Cancer
  • Gastrointestinal Neoplasms
  • Chemotherapy-Induced Thrombocytopenia
Interventions
  • DRUG
No Results Yet
NCT05756166 | TERMINATED | PHASE1/PHASE2
5 participants

Rintatolimod, Celecoxib and Interferon Alpha 2b With Pembrolizumab For the Treatment of Patients With Metastatic or Unresectable Triple Negative Breast Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-31
Start Date:
2024-02-16
Completion:
2025-04-08
Conditions
  • Anatomic Stage IV Breast Cancer AJCC v8
  • Metastatic Triple-Negative Breast Carcinoma
  • Unresectable Triple-Negative Breast Carcinoma
Interventions
  • PROCEDURE
  • DRUG
  • BIOLOGICAL
NCT05652270 | ACTIVE_NOT_RECRUITING | NA
258 participants

Maximizing Patient Goal Attainment

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-31
Start Date:
2023-05-30
Completion:
2026-11-30
Conditions
  • Knee Osteoarthritis
  • Knee Injuries
  • Knee Pain Chronic
  • Knee Injuries and Disorders
Interventions
  • BEHAVIORAL
No Results Yet
NCT05493215 | RECRUITING | PHASE2
28 participants

Imatinib TDM in GIST

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-31
Start Date:
2024-03-26
Completion:
2027-12-31
Conditions
  • Gastrointestinal Stromal Tumors
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page